key: cord-0795548-dvmhhv2b authors: Tatapudi, H. A.; Das, R.; Das, T. K. title: Impact of Vaccine Prioritization Strategies on Mitigating COVID-19: An Agent-Based Simulation Study using an Urban Region in the United States date: 2021-03-12 journal: nan DOI: 10.1101/2021.03.12.21253447 sha: 8953e070934a54ec6cdd32eaa47576421ae02de5 doc_id: 795548 cord_uid: dvmhhv2b Background Approval of novel vaccines for COVID-19 has brought hope and expectations, but not without additional challenges. One central challenge is how to appropriately prioritize the use of limited supply of vaccines. This study evaluates various prioritization strategies and the efficacy of the vaccination campaign underway in the U.S. Methods The study develops a granular agent-based simulation model for mimicking community spread of COVID-19 under various social interventions including full and partial closures, isolation and quarantine, use of face mask and contact tracing, and vaccination. The model is populated with demographic and societal data for an urban community in the U.S. with 2.8 million residents as well as viral parameters. The model tracks daily numbers of infected, hospitalized, and deaths for all census age-groups. Model is calibrated using parameters for viral transmission and level of community circulation of individuals. Published data from the Florida COVID-19 dashboard is used to validate the model. Vaccination strategies are compared using hypothesis test for pairwise comparisons. Results Three prioritization strategies examined are: a close variant of the CDC recommendation, an age-stratified strategy, and a random strategy. The impact of vaccination is also contrasted with a no vaccination scenario. The comparison shows that the ongoing campaign in the U.S. using vaccines developed by Pfizer/BioNTech and Moderna is expected to 1) reduce the cumulative number of infection by 10% and 2) help the pandemic to subside below a small threshold of 100 daily new reported cases sooner by approximately a month. The prioritization strategies when compared with each other showed no significant difference in their impacts on pandemic mitigation. Conclusions Recent explosive growth of the number of new COVID-19 cases in the U.S. continues to shrink the susceptible population. This, we believe, will likely limit the expected number of people that could be prevented from getting infected due to vaccination. A shrinking susceptible pool may also be an attributable reason for the observed lack of statistical difference among the outcomes of the prioritization strategies. However, the invariance of the strategies should give more latitude for decision makers in COVID-19 vaccine distribution. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 12, 2021. persons with high risk medical conditions for COVID-19, and older adults >65 years. These groups will be given 153 priority for vaccination in phase 1, defined as when vaccine supply is still limited. In phase 2 (supply increases to 154 begin to meet demand) and phase 3 (supply is greater than demand), other population groups begin to be vaccinated 155 based on age and availability [25] . Vaccine allocation structures with basic similarities and some key differences are 156 being used by countries around the world. For example, after healthcare workers, France's vaccine allocation is transportation, and hospitality staff [17] . Such differences in vaccine prioritization structures are as of yet untested 160 and warrant modeling and examination. The goal of this paper is to investigate the impact of vaccination on the pandemic via outcome measures of numbers 163 of infected, hospitalized, and dead in the months following December 15, 2020, when vaccination began in the U.S. Two specific objectives of our investigation are: 1) to assess the expected impact of the vaccination program that is 165 currently underway on mitigating COVID-19, and 2) to inform public health officials on the comparative benefits, if 166 any, of the different vaccine prioritization strategies. We conduct our investigation by using our agent-based (AB) 167 simulation model for COVID-19 that was presented recently in [19] . We first extended calibration of our model till 168 December 30, 2020 to ensure that our model appropriately tracks the explosive increase in cases that started with the 169 onset of winter and the year-end holiday period. We then enhanced the model by adding a framework for 170 vaccination. This included: vaccination priorities for people based on attributes including profession and age, use of 171 two different vaccines by Pfizer/BioNTech and Moderna with their contracted quantities and approximate delivery 172 timelines, acceptability of vaccines to prioritized cohorts (approximately 60% based on national survey data [3, 18] ), 173 transition period between each priority group, vaccination rate, and immunity growth for vaccinated starting with the 174 first dose. As in [19] , we implement our calibrated AB model, augmented with vaccination, for Miami-Dade County of the 177 U.S. with 2.8 million population, which has been an epicenter of COVID-19 in the U.S. We conduct our 178 investigation by implementing four different strategies (including no vaccination) and obtaining the corresponding 179 numbers of total infections, reported infections, hospitalizations, and deaths. We compare and contrast the numbers 180 to assess vaccination efficacy and relative performances of the priority strategies. The vaccination strategies that we 181 investigate are a close variant of the CDC recommended strategy, an age-stratified strategy, and finally a random 182 strategy. We make a number of key observations from the results, which we believe will help public health officials 183 around the world to choose effective vaccine prioritization strategies to mitigate the negative impacts of COVID-19. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We use an enhanced version of our AB simulation model that was developed to examine various social intervention 234 strategies for COVID-19 [19] . The AB simulation model replicates the dynamics of the pandemic outbreak by 235 incorporating: 1) population demography of the outbreak region for all age groups and employment categories, 2) 236 numbers, sizes, and compositions of households, schools, workplaces, and community places, 3) daily schedules for 237 people of all age groups before and during the intervention orders (e.g., stay-at-home), 4) isolation of infected and 238 quarantine of household members, 5) closure and reopening of schools, workplaces, and community places, 6) 239 compliance to isolation and quarantine requirements, 7) face mask usage, 8) contact tracing, 9) prioritization of 1 1 people for vaccination, 10) vaccinating those willing to receive based on supply and priority windows, 11) 241 epidemiological parameters of the virus, 12) infection spread, and 13) disease natural history. The key 242 epidemiological parameters include: disease natural history with average lengths of latent, incubation, symptomatic, 243 and recovery periods; distribution of infectiousness; percent asymptomatic; and fatality rate. As in the model presented in [19] , each day our model tracks the following for each person: 1) hourly movements 246 and locations based on their daily schedules that depend on age, employment status, prevailing social intervention for building such a model for another region can be found in [19] . The methodology begins by generating the 258 individual people according to the U.S. census data that gives population attributes including age (see Table A1 in 259 [19] ) and occupational distribution (see Table A4 in [19] ). Thereafter, it generates the households based on their 260 composition characterized by the number of adults and children (see Table A2 in [19] ). The model also generates, 261 per census data, schools (see Table A3 in [19] ) and the workplaces and other community locations (see Table A4 in 262 [19] ). Each individual is assigned a household, while maintaining the average household composition, and, 263 depending on the age, either a school or a workplace (considering employment levels). A daily (hour by hour) 264 schedule is assigned to every individual, chosen from a set of alternative schedules, based on their attributes. The 265 schedules vary between weekdays and weekends and also depend on the prevailing social intervention orders (see 266 Table A5 in [19] ). 267 268 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. [19] 304 305 The infected people are considered to follow a disease natural history as shown in Figure 3 , parameters of which can 306 be found in Table A6 of [19] . The model assumes that the recovered cases become fully immune to further COVID-307 19 infections. However, since this assumption is not fully supported yet by data, people recovered from COVID-19 308 are also considered candidates for vaccination. The duration and intensity of infectiousness is considered to be 309 guided by a lognormal density function (see Figure 4) . The function is truncated at the average length of the 310 infectiousness period (which is considered to be 9.5 days). Asymptomatic cases are assumed to follow a similar 311 infectiousness intensity profile but scaled by a factor in the force of infection calculation (1) (see Table A7 in 312 [19] ). 313 314 Figure 4 : Lognormal distribution function for infectiousness profile of a COVID-19 case [19] 315 316 The AB model estimates the probability of infection for a susceptible using the accumulated value of daily force of 317 infection ( ), which is calculated as follows. 318 5 an of All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (1) 319 320 Equation (1) As observed in [19] , though it is implemented for a specific region, our model is quite general in its usability for 338 other urban regions with similar demography, societal characteristics, and intervention measures. In our model, 339 demographic inputs (age and household distribution, number of schools for various age groups, and number of 340 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The priority strategies that were examined are broadly described here; a more complete description is presented in (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253447 doi: medRxiv preprint stratified and random strategies also yield statistically significantly lower numbers of reported cases compared to no 509 vaccination. However, comparison among the three vaccine prioritization strategies showed no significant statistical 510 difference for reported cases between strategies (p-values near 0.4). The numbers for hospitalizations and deaths 511 also had a similar trend. The model predicted values of the cumulative numbers of infected cases, reported cases, 512 hospitalized, and dead from the three policies and their 95% confidence intervals are presented in Table 2. The table 513 also provides the time frame when the pandemic falls below the threshold of 100 new reported cases. We observed 514 from the Florida COVID-19 dashboard that reported numbers of deaths are the most inconsistent of all reported data 515 due to reasons like: the timeline for deaths occurring from COVID-19 is highly variable, and deaths occur at homes, 516 hospitals, long term care facilities for which the reporting mechanism is perhaps not as streamlined. Hence, we 517 applied the percentages of deaths of those hospitalized in various age groups in the month of November 2020 to all 518 the subsequent months of our simulation study (till end of July 2021 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Another noteworthy finding of this study was that there was no statistical difference in number of reported cases 547 between vaccination prioritization strategies tested: CDC recommendation based strategy, strictly age-based 548 strategy, and random strategy. This information can help give more latitude for decision makers in COVID-19 549 vaccine distribution, as this research suggests that adhering strictly to priority groups may not be as paramount to 550 vaccination campaign success as simply distributing the vaccines. 551 552 Though our AB model is well suited to study future progression of COVID-19, it has some limitations. As 553 mentioned under vaccination strategies, our model did not include health conditions that are relevant to COVID-19 554 (like pulmonary disease, obesity, heart problems) as attributes for people. Hence, we were not able to implement one 555 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253447 doi: medRxiv preprint element of the CDC recommended prioritization strategy that includes people aged 16-64 years with underlying 556 medical conditions in priority 3. Also, we did not consider any vaccine wastage due to complexities associated with 557 refrigeration, distribution, and human error. We also assumed that vaccination of all priority groups will occur 558 uniformly over the eligibility periods considered, which may not reflect the reality. Also, since, to our knowledge, 559 there is little available literature on the rate of immunity growth each day from the two dose vaccines, we assumed a 560 linear growth starting with the first dose and culminating (full immunity) seven days after the second dose. Lastly, 561 as the pandemic progresses, new strains of the virus are being identified with slightly different viral parameters that 562 may not receive full coverage from the vaccine. It is unclear how this will impact the pandemic projection presented 563 in this model, though latest research shows that those vaccinated are likely to be protected from the new strains. 564 565 Unlike highly aggregated compartmental models that are relatively easy to apply to multiple regions/countries, 566 agent-based models are highly granular and require extensive data collection for the application region. The data 567 include population in all age groups, household compositions of adults and children, essential and non-essential 568 businesses and factories of different sizes as places for employment, schools and colleges of different sizes for 569 different age groups, peoples schedule on weekdays and weekends during different social intervention phases, 570 intervention timelines, testing availability and reporting delays, quarantine, isolation, and mask usage compliance, 571 and level of contact tracing. Hence, implementing the AB model to another region is a major task (see [19] for a 572 step-by-step approach). As vaccination is ramping up in earnest in the U.S. at the time of our study, we believe that our results will provide 575 useful information for the healthcare policy makers not only for Miami-Dade County but for similar urban regions in 576 the U.S. and perhaps elsewhere in the world with a similar demography. 584 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.12.21253447 doi: medRxiv preprint COVID vaccine willingness waned since April. Center for Infectious Disease Research 585 and Policy Optimal Dynamic Prioritization of Scarce COVID-19 Vaccines Evolution and epidemic spread of 590 SARS-CoV-2 in Brazil FluTE, a publicly available stochastic influenza epidemic 592 simulation model COVID-19 virus outbreak forecasting of registered and recovered 594 cases after sixty day lockdown in Italy: A data driven model approach Cost-Effectiveness of a Recommendation of 597 Universal Mass Vaccination for Seasonal Influenza in the United States. Value in Health Transmission dynamics of the COVID 19 outbreak and effectiveness of 600 government interventions: A data driven analysis Estimating disease burden of a potential 602 A(H7N9) pandemic influenza outbreak in the United States The effectiveness of quarantine of Wuhan city against the 604 COVID 19): A well mixed SEIR model analysis Modelling the strategies for age specific vaccination scheduling during influenza pandemic 610 outbreaks Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children Finding optimal vaccination strategies for pandemic influenza using genetic 614 algorithms Epidemic analysis of COVID-19 in China by dynamical 616 modeling Who should get the coronavirus vaccine first? France and the UK have different 618 answers. The Conservation Impact assessment of full and partial stay-at-home orders, face mask usage, and 625 contact tracing: An agent-based simulation study of COVID-19 for an urban region Early estimation of the case fatality rate of COVID-19 in 628 mainland China: a data-driven analysis Modified SEIR and AI prediction of the epidemics 630 trend of COVID-19 in China under public health interventions The impact of social distancing and epicenter lockdown on the COVID-19 632 epidemic in mainland China: A data-driven SEIQR model study Pfizer and BioNtech conclude Phase 3 study of COVID-19 vaccine candidate, meeting all primary efficacy 634 endpoints COVID-19 Vaccines. US Food & Drug Administration The City of Miami Florida's COVID-19 Data and Surveillance Dashboard,. Florida Department of Health, Division of Disease 648 Control and Health Protection Framework for equitable allocation of COVID-19 vaccine [Internet]. The National Academy Press